Healthcare provider profile · identity verified

Leslie E Myers, D.O.

Internal Medicine · CANANDAIGUA, NY · NPI 1215930375

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	717	57
Mirtazapine	Mirtazapine	644	79
Levothyroxine Sodium	Levothyroxine Sodium	592	89
Sertraline Hcl	Sertraline Hcl	468	49
Atorvastatin Calcium	Atorvastatin Calcium	435	67
Gabapentin	Gabapentin	398	49
Pantoprazole Sodium	Pantoprazole Sodium	306	54
Amlodipine Besylate	Amlodipine Besylate	300	46
Metoprolol Tartrate	Metoprolol Tartrate	290	49
Lisinopril	Lisinopril	284	39
Torsemide	Torsemide	268	43
Escitalopram Oxalate	Escitalopram Oxalate	260	40
Myrbetriq	Mirabegron	254	14
Quetiapine Fumarate	Quetiapine Fumarate	234	26
Famotidine	Famotidine	227	35
Trazodone Hcl	Trazodone Hcl	227	38
Duloxetine Hcl	Duloxetine Hcl	220	34
Tamsulosin Hcl	Tamsulosin Hcl	198	33
Donepezil Hcl	Donepezil Hcl	186	29
Carbidopa-Levodopa	Carbidopa/Levodopa	174	25
Divalproex Sodium	Divalproex Sodium	173	23
Omeprazole	Omeprazole	170	26
Furosemide	Furosemide	165	32
Metformin Hcl	Metformin Hcl	165	23
Losartan Potassium	Losartan Potassium	151	27
Metoprolol Succinate	Metoprolol Succinate	135	26
Memantine Hcl	Memantine Hcl	126	17
Xarelto	Rivaroxaban	125	11
Fluoxetine Hcl	Fluoxetine Hcl	108	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	93	13
Levetiracetam	Levetiracetam	90	15
Finasteride	Finasteride	88	12
Hydralazine Hcl	Hydralazine Hcl	86	suppressed
Carvedilol	Carvedilol	82	11
Latanoprost	Latanoprost	80	16
Fluticasone Propionate	Fluticasone Propionate	76	21
Allopurinol	Allopurinol	75	14
Prednisone	Prednisone	70	16
Potassium Chloride	Potassium Chloride	69	17
Buspirone Hcl	Buspirone Hcl	66	11
Risperidone	Risperidone	65	suppressed
Midodrine Hcl	Midodrine Hcl	64	suppressed
Atenolol	Atenolol	63	suppressed
Diclofenac Sodium	Diclofenac Sodium	63	30
Simvastatin	Simvastatin	62	suppressed
Bethanechol Chloride	Bethanechol Chloride	61	suppressed
Clopidogrel	Clopidogrel Bisulfate	61	suppressed
Pravastatin Sodium	Pravastatin Sodium	61	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	58	58
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	11
Fludrocortisone Acetate	Fludrocortisone Acetate	52	suppressed
Glipizide	Glipizide	51	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	51	14
Carbidopa-Levodopa Er	Carbidopa/Levodopa	47	suppressed
Divalproex Sodium Er	Divalproex Sodium	46	suppressed
Glimepiride	Glimepiride	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	14
Labetalol Hcl	Labetalol Hcl	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Amantadine	Amantadine Hcl	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Diltiazem Hcl	Diltiazem Hcl	36	suppressed
Baclofen	Baclofen	35	suppressed
Irbesartan	Irbesartan	35	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Valsartan	Valsartan	33	suppressed
Digoxin	Digoxin	32	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	29	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Trospium Chloride	Trospium Chloride	29	suppressed
Glycopyrrolate	Glycopyrrolate	28	suppressed
Metronidazole	Metronidazole	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Nystatin	Nystatin	26	15
Primidone	Primidone	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Phenytoin	Phenytoin	24	suppressed
Topiramate	Topiramate	24	suppressed
Lumigan	Bimatoprost	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Naproxen	Naproxen	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Budesonide	Budesonide	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Atropine Sulfate	Atropine Sulfate	20	13
Azelastine Hcl	Azelastine Hcl	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lamotrigine Er	Lamotrigine	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Cholestyramine Light	Cholestyramine	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Risedronate Sodium	Risedronate Sodium	16	suppressed
Tacrolimus	Tacrolimus	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Methimazole	Methimazole	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	14	suppressed
Galantamine Hbr	Galantamine Hbr	14	suppressed
Levetiracetam Er	Levetiracetam	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Budesonide Ec	Budesonide	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lactulose	Lactulose	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Loteprednol Etabonate	Loteprednol Etabonate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Abiraterone Acetate	Abiraterone Acetate	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error